About John

John B. Hale's practice focuses on capital call, subscription and management company facilities, in addition to the range of venture debt products. He represents banks, venture debt funds and companies in connection with the making and unmaking of credit arrangements, including simple and not simple loans, warrants and related matters.

View full bio

Experience

  • Asymchem Agrees to Acquire Snapdragon Chemistry

    • Asymchem Agrees to Acquire Snapdragon Chemistry

    February 12, 2022

    Cooley advised Asymchem, a Chinese-based contract development and manufacturing company serving the global pharmaceutical and biotech industry, on its definitive agreement to acquire Snapdragon Chemistry, a US-based chemical technology company. Partner Yiming Liu led the Cooley team.

    As a result of the transaction, Asymchem will significantly expand its footprint in the US, offering customers a seamless path from preclinical process R&D through commercial current good manufacturing practice (cGMP) production. Snapdragon will operate as a stand-alone Asymchem division, and continue with its ongoing lab and manufacturing facility expansion for additional capacity to support larger, pilot-scale manufacturing in Waltham, Massachusetts.

    "We believe continuous flow manufacturing is a revolutionary technology and represents the future of pharmaceutical production, not only generating advantages to process safety and cost, but also bringing tremendous environmental benefits," Hao Hong, chairman and CEO of Asymchem, said in a news release. "Asymchem has been deeply committed to flow chemistry technology development and its application expansion in the pharmaceutical industry for more than a decade. We are excited that this strategic acquisition will further strengthen our capabilities in continuous manufacturing, as well as broadening our service scope and client pool."

    Related contacts

    Yiming Liu
    Partner in Charge – Shanghai, Shanghai
    Yiying Wang
    Counsel, Shanghai
    Yunxiang Xu
    Associate, Shanghai
    Howard Morse
    Senior Counsel, Washington, DC
    Christopher Kimball
    Partner, Washington, DC
    Aaron Pomeroy
    Partner, Colorado
    Kathleen Goodhart
    Partner, San Francisco
    Rama Padmanabhan
    Partner, San Diego
    John Hale
    Senior Counsel , Palo Alto
    John Lavoie
    Partner in Charge – Reston, Reston
    Sonia Nath
    Partner, Washington, DC
    Andrew Harline
    Partner in Charge – Singapore, Singapore
    Bridget R. Reineking
    Special Counsel, Washington, DC
    Natasha Leskovsek
    Of Counsel, Washington, DC
    Peter Crain
    Special Counsel, Reston
    Stella Sarma
    Partner, Brussels
    Karen Tsai
    Special Counsel, Washington, DC
    Dillon Martinson
    Special Counsel, Washington, DC
    Erica Russell
    Associate, San Francisco
    Zoë Helstrom
    Associate, San Francisco
    Sai Yarramalla
    Associate, Palo Alto
    Patrick Sharma
    Associate, Santa Monica
    Katie Adams
    Associate, Reston
    Sarah Oliai
    Associate, Washington, DC
    Kate Walther
    Paralegal Specialist, San Diego

    Related Practices & Industries

    Mergers and Acquisitions
    Life Sciences and Healthcare
    Healthcare

  • Cedar Closes $102 Million Series C

    • Cedar Closes $102 Million Series C

    July 17, 2020

    Cooley advised Cedar in its $102 million Series C financing led by Andreessen Horowitz. Partner Sacha Ross led the Cooley team advising Cedar, a patient engagement and healthcare financial technology platform.

    Related contacts

    Sacha Ross
    Partner, New York
    Robert Warshaw
    Associate, New York
    John Hale
    Senior Counsel , Palo Alto

    Related Practices & Industries

    Emerging Companies
    Venture Capital

Admissions and credentials

  • California
  • Wisconsin

Rankings and accolades

Best Lawyer in America: Banking and Finance Law (2013 – 2019)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.